Eliem Therapeutics shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of Eliem Therapeutics (CLYM) shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in Eliem Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Eliem Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Eliem Therapeutics by T. Rowe Price Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $13M | 1.9M | 6.85 |
| 2025-12-31 | $7.7M | 1.9M | 4.00 |
| 2025-09-30 | $1.1M | 527k | 2.01 |
| 2025-06-30 | $680k | 548k | 1.24 |
| 2025-03-31 | $715k | 586k | 1.22 |
| 2024-12-31 | $1.1M | 629k | 1.80 |
| 2024-09-30 | $3.4M | 673k | 5.09 |